As Peptides Go Mainstream, CeliaRx Aims To Cut Through The Noise
CeliaRx, a new telehealth platform, aims to simplify the rapidly growing peptide market for consumers seeking proactive health solutions. The company offers physician-guided peptide protocols, delivering treatments directly to patients' homes after personalized consultations. Founder Koehl Robinson was inspired by her own positive experience with peptide therapy after facing significant health challenges, leading her to address the confusion and fragmentation in the current peptide market. AI
IMPACT Niche tooling improvement; minimal industry-wide impact.